Table 1.
Brain Cohort Demographics
| Control n = 72 | Schizophrenia n = 72 | t value | P value | |
| Age | 47.8 ± 1.43 (18–78) | 47.1 ± 1.47 (19–75) | 0.34 | .74 |
| Gender | 16F/56M | 22F/50M | ||
| pH | 6.63 ± 0.03 (5.84–7.15) | 6.55 ± 0.03 (5.69–7.09) | 1.87 | .06 |
| PMI | 27 ± 1.42 (6.50–58) | 29.9 ± 1.72 (5.0–80) | −1.28 | .20 |
| RIN | 7.78 ± 0.09 (6.0–9.70) | 7.85 ± 0.10 (6.20–9.60) | −0.53 | .59 |
| Brain weight (g) | 1445.2 ± 16.1 (1120–1900) | 1417.6 ± 16.6 (1020–1700) | 1.20 | .23 |
| Age of onset (y) | 22.5 ± 0.72 (9–40) | |||
| DOI (y) | 24.5 ± 1.47 (1–52) | |||
| Lifetime APD use | 3952352 ± 809053.2 |
Note: Cohort is a combination of the Tissue Resource Centre (TRC) (n = 37/37) and Stanley Medical Research Institute (SMRI) (n = 35/35) cohorts. Demographics are presented as mean values ±SEM. The lowest and highest values of each variable are listed in brackets. Race: TRC cohort: 2 Asians, 72 Caucasians. SMRI cohort: 1 Native American, 1 African American, 1 Hispanic, 67 Caucasians. M, male; F, female; PMI, postmortem interval; RIN, RNA integrity number; DOI, duration of illness; APD, antipsychotic drug.